The history of operations to correct renal artery stenosis is reviewed and the results of surgical treatment in 125 cases are described. Nephrectomy is indicated for severe degrees of renal atrophy, multiple branch lesions and unsuccessful previous arterioplasty. The results of partial nephrectomy for branch disease are generally poor. Endarterectomy is indicated for well defined atherosclerotic plaques and resection and reanastomosis is useful for discrete and short stenosing lesions but bypass grafts are the most popular and useful reconstructive operations. Generally good results have been obtained with dacron bypass grafts but long term evaluation is needed to determine late patency. The sþlenorenal bypass is an excellent choice for lesions of the left renal artery when the splenic artery is normal. General guides in the performance of operations on the renal vessels are given and the future of renovascular surgery is discussed with reference to possible usefulness of autotransplantation of the kidney and selection of medical vs. surgical therapy for patients with diffuse vascular disease, advanced age and irremediable renovascular lesions.

This content is only available via PDF.
© 1969 S. Karger AG, Basel
1969
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.